Baolingbao Biology Revenue

Baolingbao Biology had revenue of 747.84M CNY in the quarter ending March 31, 2026, with 9.21% growth. This brings the company's revenue in the last twelve months to 2.81B, up 10.99% year-over-year. In the year 2025, Baolingbao Biology had annual revenue of 2.75B with 14.54% growth.

Revenue (ttm)

2.81B

Revenue Growth

+10.99%

P/S Ratio

1.38

Revenue / Employee

2.02M

Employees

1,395

Market Cap

3.87B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.75B	349.27M	14.54%
Dec 31, 2024	2.40B	-122.16M	-4.84%
Dec 31, 2023	2.52B	-188.83M	-6.96%
Jan 1, 2023	2.71B	-52.23M	-1.89%
Jan 1, 2022	2.76B	710.40M	34.58%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Boji Medical Technology	949.94M
Guanhao Biotech	387.75M
Qingdao Vland Biotech INC.	1.37B
Shanghai Serum Bio-Technology	197.68M
Zhejiang Wecome Pharmaceutical Company	131.67M
Zhejiang Shouxiangu Pharmaceutical	642.66M
Pulike Biological Engineering	1.10B
Shanghai Shen Lian Biomedical	288.27M

Revenue Rankings